Prognostic mutation signature would serve as a potential prognostic predictor in patients with diffuse large B-cell lymphoma.

Cho SF, Yeh TJ, Wang HC, Du JS, Gau YC, Lin YY, Chuang TM, Liu YC, Hsiao HH, Moi SH

Open source

DOI
10.1038/s41598-024-56583-4
Published
2024 Mar 14
Container
Scientific reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41598-024-56583-4,
  title = {Prognostic mutation signature would serve as a potential prognostic predictor in patients with diffuse large B-cell lymphoma.},
  author = {Cho SF and Yeh TJ and Wang HC and Du JS and Gau YC and Lin YY and Chuang TM and Liu YC and Hsiao HH and Moi SH},
  year = {2024},
  journal = {Scientific reports},
  doi = {10.1038/s41598-024-56583-4},
  url = {https://doi.org/10.1038/s41598-024-56583-4}
}

RIS

TY  - JOUR
TI  - Prognostic mutation signature would serve as a potential prognostic predictor in patients with diffuse large B-cell lymphoma.
AU  - Cho SF
AU  - Yeh TJ
AU  - Wang HC
AU  - Du JS
AU  - Gau YC
AU  - Lin YY
AU  - Chuang TM
AU  - Liu YC
AU  - Hsiao HH
AU  - Moi SH
PY  - 2024
JO  - Scientific reports
DO  - 10.1038/s41598-024-56583-4
UR  - https://doi.org/10.1038/s41598-024-56583-4
ER  - 

APA

SF, C., TJ, Y., HC, W., JS, D., YC, G., YY, L., TM, C., YC, L., HH, H., & SH, M. (2024). Prognostic mutation signature would serve as a potential prognostic predictor in patients with diffuse large B-cell lymphoma.. Scientific reports. https://doi.org/10.1038/s41598-024-56583-4

Source records